Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
ATLANTA, GA, June 29, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human immunotherapies and vaccines against infectious diseases...
-
ATLANTA, GA, June 29, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human immunotherapies and vaccines against infectious diseases...
-
ATLANTA, GA, June 10, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human immunotherapies and vaccines against infectious diseases...
-
ATLANTA, GA, June 04, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE --GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human immunotherapies and vaccines against infectious diseases...
-
Progress on COVID-19 Vaccine Development; Continued Advancements in Other Infectious Disease and Immuno-Oncology Programs ATLANTA, GA, May 06, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax...
-
ATLANTA, GA, April 30, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTC: GOVX), a biotechnology company developing human vaccines and immunotherapies against infectious diseases...
-
Company Ready to Advance COVID-19 Vaccine Candidates to Animal Efficacy Testing, Manufacturing Scale-Up, and Human Clinical Trials ATLANTA, GA, March 30, 2020 (GLOBE NEWSWIRE) -- via...
-
Recent Pivot to COVID-19 Vaccine Development;Continued Advancements in Other Infectious Disease and Immuno-Oncology Programs ATLANTA, GA, March 25, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE --...
-
Three Vaccine Candidates Completed Nearing Readiness for Animal Efficacy Testing and Human Clinical Trials ATLANTA, GA, March 18, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs,...
-
Update Given During Presentation at the World Immunotherapy Congress ATLANTA, GA, March 04, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTC: GOVX), a biotechnology company...